Profile
Sergio Marullo di Condojanni is Chief Executive Officer at Angelini Pharma SpA since 2026, Chief Executive Officer at Angelini Industries since 2020, Chief Executive Officer at Angelini Finanziaria SpA since 2017, Chief Executive Officer & Director at Angelini Holding SpA since 2020, Independent Director at Tamburi Investment Partners SpA since 2022, Director at Bambino Gesu Hospital since 2023, and Director at Catalyst Pharmaceuticals, Inc. since 2026.
Formerly, Dr. di Condojanni was Director at Banca Aletti SpA from 2018 to 2022.
Education includes a doctorate conferred in 2007 and a graduate degree from The LUISS University of Rome.
Sergio Marullo di Condojanni active positions
| Companies | Position | Start |
|---|---|---|
| TAMBURI INVESTMENT PARTNERS S.P.A. | Director/Board Member | 2021-12-31 |
| CATALYST PHARMACEUTICALS, INC. | Director/Board Member | 2026-07-14 |
Angelini Holding SpA
Angelini Holding SpA Financial ConglomeratesFinance Operates as a holding company that manages equity investments in healthcare, consumer and industrial technology sectors | Chief Executive Officer | 2020-06-30 |
Angelini Finanziaria SpA
Angelini Finanziaria SpA MiscellaneousMiscellaneous Functions as an investment holding company | Chief Executive Officer | 2016-12-31 |
Bambino Gesu Hospital | Director/Board Member | 2023-09-30 |
Angelini Pharma SpA
Angelini Pharma SpA Pharmaceuticals: MajorHealth Technology Develops drugs | Chief Executive Officer | 2026-01-20 |
Former positions of Sergio Marullo di Condojanni
| Companies | Position | End |
|---|---|---|
Banca Aletti & C. SpA
Banca Aletti & C. SpA Investment Banks/BrokersFinance Provides brokerage services | Director/Board Member | 2021-12-31 |
Training of Sergio Marullo di Condojanni
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets novel medicines for patients living with rare diseases | Health Technology |
Tamburi Investment Partners SpA
Tamburi Investment Partners SpA Financial ConglomeratesFinance Specializes in venture capital activities | Finance |
Banca Aletti & C. SpA
Banca Aletti & C. SpA Investment Banks/BrokersFinance Provides brokerage services | Finance |
The LUISS University of Rome
The LUISS University of Rome Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Angelini Finanziaria SpA
Angelini Finanziaria SpA MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Bambino Gesu Hospital | |
Angelini Holding SpA
Angelini Holding SpA Financial ConglomeratesFinance Operates as a holding company that manages equity investments in healthcare, consumer and industrial technology sectors | Finance |
Angelini Pharma SpA
Angelini Pharma SpA Pharmaceuticals: MajorHealth Technology Develops drugs | Health Technology |
- Stock Market
- Insiders
- Sergio Marullo di Condojanni
















